The COVID-19 pandemic exposed healthcare system vulnerabilities, disrupting supply chains, impacting inventory, PPE stockpiles, and staff shortages, highlighting the need for improved safety measures. Digital stockpiling offers benefits like reliable devices and addressing supply chain disruptions, but implementation is challenging. The good news is that 92% of companies surveyed are investing in new technologies, emphasizing the recognition of the need for digital supply chains. One way is to invest in additive manufacturing (AM or 3D printing). AM enables medical manufacturers to rapidly increase production of products like PPE and nasal swabs, reducing supply chain disruptions. It facilitates decentralized manufacturing, allowing parts to be printed and built globally, reducing downtime. This approach simplifies entry barriers, promoting sustainable equipment manufacturing with less waste.